 The purpose of this study is to research the effects of ketamine on brain function in patients with Major Depressive Disorder MDD. This study is an ancillary MRI neuroimaging study being conducted in patients with MDD who are enrolled in a separate clinical trial. Healthy control volunteers are also enrolled. No drug or other intervention is given as part of this protocol per se. 